GFAP and Parkinson disease: Unlike other diseases (e.g., brain injury, Alzheimer’s disease, Parkinson’s disease, etc.)where astrocytic activity is increased and GFAP (glial fibrillary acidic protein) proliferation (astrogliosis) is predominant, MDD patients exhibit reduced numbers and smaller size.